Scientists have revealed that a new drug can help prevent advanced breast cancer from progressing, which could provide a groundbreaking treatment option for women with the potentially fatal disease.
The researchers said that the drug, palbociclib, cut in half the risk that the cancer would worsen.
Dr. Richard S. Finn, a principal investigator, said that the magnitude of benefit they are seeing is not something commonly seen in cancer medicine studies.
The drug, which is being developed by pharmaceutical giant, Pfizer, appears to prolong survival, though not by a statistically significant amount.
Finn added that a statistically significant survival benefit should not have been expected at this point because only 61 of the 165 patients in the trial had died.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app